Selective delivery of doxorubicin by novel stimuli-sensitive nano-ferritins overcomes tumor refractoriness

Affiliations

• ¹ Department of Medicine, University of Verona, 37134 Verona, Italy.
• ² Institute of Molecular Biology and Pathology, CNR - National Research Council of Italy, 00185 Rome, Italy.
• ³ Department of Anatomical, Histological, Forensic & Orthopedic Sciences, Section of Histology & Medical Embryology, "Sapienza" University, 00161 Rome, Italy.
• ⁴ Oncogenomics and Epigenetics, Regina Elena National Cancer Institute, 00144 Rome, Italy.
• ⁵ Institute of Biochemistry and Clinical Biochemistry, Catholic University, 00168 Rome, Italy.
• ⁶ Digestive Surgery Division, Department of Surgical Sciences, Catholic University, 00168 Rome, Italy.
• ⁷ Institute of Molecular Biology and Pathology, CNR - National Research Council of Italy, 00185 Rome, Italy; Department of Biochemical Sciences "A. Rossi-Fanelli", "Sapienza" University, 00185 Rome, Italy; Center for Life Nano Science at "Sapienza" University, Italian Institute of Technology (IIT), 00161 Rome, Italy.
• ⁸ Department of Neurological and Movement Sciences, University of Verona, 37134 Verona, Italy.
• ⁹ Institute of Biochemistry and Clinical Biochemistry, Catholic University, 00168 Rome, Italy. Electronic address: [email protected].
• ¹⁰ Institute of Molecular Biology and Pathology, CNR - National Research Council of Italy, 00185 Rome, Italy. Electronic address: [email protected].